SEC Form 4 · accession 0001479791-17-000004
INVO Bioscience, Inc. · IVOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Claude Ranoux
10% Owner
Period of report
Jun 19, 2017
Accepted (ET)
Dec 28, 2017 · 2:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001417926
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| INVO Bioscience Common Stock | Jun 19, 2017 | S | 100,000 | $0.30 | D | 26,973,122 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This transaction was initially filed with the SEC on June 19, 2017 and was inadvertently reported on a wrong Form Schedule 13D.